S
Suphak Vanichseni
Researcher at Centers for Disease Control and Prevention
Publications - 32
Citations - 1794
Suphak Vanichseni is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Population. The author has an hindex of 20, co-authored 32 publications receiving 1772 citations. Previous affiliations of Suphak Vanichseni include Mahidol University & Yeshiva University.
Papers
More filters
Journal ArticleDOI
Intersubtype Human Immunodeficiency Virus Type 1 Superinfection following Seroconversion to Primary Infection in Two Injection Drug Users
Artur Ramos,Dale J. Hu,Lily Nguyen,Kim Oanh Phan,Suphak Vanichseni,Nattawan Promadej,Kachit Choopanya,Margaret E. Callahan,Nancy L. Young,Janet M. McNicholl,Timothy D. Mastro,Thomas M. Folks,Shambavi Subbarao +12 more
TL;DR: The data show that, in some individuals, the quality and quantity of the immune response elicited by primary HIV-1 infection may not protect against superinfection, which has important implications for vaccine design.
Journal ArticleDOI
The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials.
Marcia L. Kalish,Baldwin A,Raktham S,Wasi C,Chi-Cheng Luo,Gerald Schochetman,Timothy D. Mastro,Neal S. Young,Suphak Vanichseni,Rübsamen-Waigmann H +9 more
TL;DR: The genetic diversity within subtypes B', and E in Thailand, and the proportion of new infections due to subtype E viruses among Bangkok IDU are increasing significantly, highlighting the importance of monitoring the molecular epidemiology of HIV-1 in populations being considered for HIV- 1 vaccine trials.
Journal ArticleDOI
Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand.
Suphak Vanichseni,Dwip Kitayaporn,Timothy D. Mastro,Timothy D. Mastro,Philip A. Mock,Suwanee Raktham,Don C. Des Jarlais,Sathit Sujarita,La Ong Srisuwanvilai,Nancy L. Young,Chantapong Wasi,Shambavi Subbarao,William L. Heyward,William L. Heyward,José Esparza,Kachit Choopanya +15 more
TL;DR: HIV-1 transmission risk remains high among Bangkok IDUs despite methadone treatment and other current prevention strategies, and this study led to the initiation in 1999 of a phase III HIV-1 vaccine efficacy trial in this population.
Journal ArticleDOI
Estimating the number of HIV-infected injection drug users in Bangkok: a capture--recapture method.
Timothy D. Mastro,Dwip Kitayaporn,Bruce G. Weniger,Suphak Vanichseni,V Laosunthorn,T Uneklabh,C Uneklabh,Kachit Choopanya,Khanchit Limpakarnjanarat +8 more
TL;DR: During the 1990s the number of cases of acquired immunodeficiency syndrome (AIDS) and other HIV-related diseases, including tuberculosis, in the population of HIV-infected injection drug users in Bangkok will increase dramatically, placing new demands on existing health care facilities.
Journal ArticleDOI
Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E.
Chantapong Wasi,Herring B,Suwanee Raktham,Suphak Vanichseni,Timothy D. Mastro,Nancy L. Young,H. Rübsamen-Waigmann,von Briesen H,Marcia L. Kalish,Chi-Cheng Luo +9 more
TL;DR: HMA, and PEIA are practical, sensitive, and specific laboratory methods for the determination of HIV-1 subtypes in Thailand, and may be useful in other geographic areas to define the molecular epidemiology of the global HIV- 1 pandemic.